Krebs–Henseleit solution (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Krebs–Henseleit solution" in English language version.

refsWebsite

Global rank English rank

2^nd place

low place

low place

4^th place

cshlp.org

"Krebs-Henseleit (KH) Buffer". Cold Spring Harbor Protocols. 2006: pdb.rec581. 1 June 2006. doi:10.1101/pdb.rec581. Retrieved 6 May 2021.

"Krebs-Henseleit (KH) Buffer". Cold Spring Harbor Protocols. 2006: pdb.rec581. 1 June 2006. doi:10.1101/pdb.rec581. Retrieved 6 May 2021.
Quan A, Leung SW, Lao TT, Man RY (December 2003). "5-hydroxytryptamine and thromboxane A2 as physiologic mediators of human umbilical artery closure". J. Soc. Gynecol. Investig. 10 (8): 490–5. doi:10.1016/S1071-5576(03)00149-7. PMID 14662162.
Bailey, Leslie E.; Ong, Seok D. (August 1978). "Krebs-Henseleit solution as a physiological buffer in perfused and superfused preparations". Journal of Pharmacological Methods. 1 (2): 171–175. doi:10.1016/0160-5402(78)90022-0. Retrieved 6 May 2021.

Bailey, Leslie E.; Ong, Seok D. (August 1978). "Krebs-Henseleit solution as a physiological buffer in perfused and superfused preparations". Journal of Pharmacological Methods. 1 (2): 171–175. doi:10.1016/0160-5402(78)90022-0. Retrieved 6 May 2021.

Quan A, Leung SW, Lao TT, Man RY (December 2003). "5-hydroxytryptamine and thromboxane A2 as physiologic mediators of human umbilical artery closure". J. Soc. Gynecol. Investig. 10 (8): 490–5. doi:10.1016/S1071-5576(03)00149-7. PMID 14662162.